So what is autism, exactly?

Essy Knopf autism spectrum disorder
Keenan Constance/Pexels
Reading time: 8 minutes

What is autism spectrum disorder? To fully understand this phenomenon, we have to employ the medical model.

Big disclaimer: the medical model is far from perfect.

According to this model, there is something inherently wrong with autistics. Historically, this rationale has also been used to marginalize and oppress us.

For most people, the social model is preferable, as it argues that the issue lies not with neurodiversity, but with society’s failure to accommodate it

The social model aims to destigmatize autism, whereas the goal of the medical model is to diagnose and treat.

Pathologizing aside, getting an ASD diagnosis can open the door to disability-related legal protections, supports, and services. This is one example of how the medical model can be of use to those with autism, and their loved ones.

So, what is autism spectrum disorder?

According to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5), autism spectrum disorder (ASD) is a neurological developmental disability.

Autism is characterized by ongoing deficits in social communication and social interactions in a range of contexts. Other criteria for autism include “restricted, repetitive patterns of behavior, interests, or activities”. 1 2

Autism symptoms manifest in the early development period and typically cause clinically significant impairment in key areas of functioning. 

To receive a diagnosis of ASD, these symptoms must not be better explained by the presence of intellectual disability or global developmental delay.

A diagnosis of ASD is typically accompanied by a severity measurement of “Level 1”, “2”, or “3”. Level 1 means the individual requires very support, Level 2 substantial support, and Level 3 very substantial support.

(Remember how I mentioned the medical model is pathologizing? An example of this is the DSM-5 terminology I just used, such as “disability”, “deficits”, “symptoms”, “impairments”, and “severity”.)

Autism often appears alongside other conditions, such as epilepsy, attention-deficit/hyperactivity disorder, sleep problems, gastrointestinal symptoms, anxiety, and depression.

Who gets diagnosed with autism spectrum disorder?

Males are diagnosed with autism at three times the rate of females, but this doesn’t necessarily mean autism isn’t as common among females.3

One study found that autistic females as a population are better than males at hiding their autistic traits. This results in fewer diagnoses, later diagnoses in life, and misdiagnoses. 

It’s also been argued that autistic females may present autism in a way different from their male counterparts.4 And due to many measurements being male-centric, females may be overlooked by current diagnostic measurements.5

Additionally, autistics from racial minority groups are typically less likely to receive a diagnosis of ASD.6 Instead, they are more likely to receive other diagnoses such as ADHD and conduct and adjustment disorders.7

Many conclude that reflects medical disadvantages experienced by minority groups as a result of structural inequality.8 But it’s important to note that autism traits can also go overlooked or can be misinterpreted, depending on the sociocultural context. 9

Why are some people autistic and others not? 

There are no clear answers here, however, some studies point to a range of environmental risk factors and protective factors. 

These include advanced parental age, low birth weight,10 11 fetal exposure to the epilepsy medication valproate,12 intake of certain vitamins,13 maternal autoimmune disorders, environmental toxins, and breastfeeding.14

Links have been made between unique gut microbiota compositions and the development of autism. Other studies have indicated strong genetic influences, concluding that autism is highly inheritable.15 16 17

How does one get an autism spectrum disorder diagnosis?

To get an autism spectrum disorder diagnosis, you need to be screened by a trained professional. 

For children, there’s a range of tools. For example, the Modified Checklist for Autism in Toddlers Revised, the Ages and Stages Questionnaire, and the Screening Tool for Autism in Toddlers and Young Children.18 19 20

For older adolescents and adults, the gold standard for autism diagnoses is the Autism Diagnostic Observation Schedule (ADOS-2) module 4.21 Professionals typically use this tool alongside direct observations and taking patient history.

The Autism Diagnostic Interview-Revised (ADI-R) is another gold standard autism diagnostic tool that is suitable for both children and adults.22

Again, I want to point out here that these diagnostic tools may be gender-biased and thus more likely to detect male autistics than female autistics.

When seeking out a diagnosis, it is worth checking to see that the person doing the assessment is using the most current, research-backed screening measures.

If seeing a professional is not an option, adults can also use self-reporting tools such as the Social Responsiveness Scale, Second Edition: Adult form (SRS-2).23

Additional tools are available for assessing how autism is impacting one’s activities of daily living and quality of life.

How is autism spectrum disorder “treated”?

There is no biomedical treatment for autism spectrum disorder, however, psychotropic medications are available and often prescribed for those who are experiencing symptoms such as anxiety or depression.24 25 26

For autism specifically, there is a range of therapies, the most commonly used being Applied Behavior Analysis (ABA).27

ABA is designed to help autistic children with the development of social, communication, and expressive language skills.

The dominant strain of ABA has been heavily criticized by autism advocates for violating individual autonomy and even doing direct harm to clients.28

Critics have also pointed out that there are conflicts of interest among researchers who publish scientific literature in support of ABA as an autism intervention.29

Clearly, there is room for improvement when it comes to current ABA intervention. However, ABA is one of the few treatments that remain widely accessible. 

In many US states, health insurance providers are required to cover ABA-related expenses under the Patient Protection and Affordable Care Act.

One alternative to mainstream ABA is Naturalistic Developmental Behavioral Interventions (NDBI). NDBI is more child-directed and provides intrinsic rewards for learning and participating.30

Other available interventions support the development of core skills among autistic children, such as social communication.31

Additionally, programs exist for young adults, such as the Program for the Education and Enrichment of Relational Skills (PEERS®).32

For autistic young people and adults, psychotherapies such as Cognitive Behavioral Therapy are recommended for those who experience comorbidities such as anxiety and depression.33 34

These are available in both individual and group formats.35

Wrap up

So there you have it, my brief introduction to autism spectrum disorder.

Again, I want to stress that much of the content I shared is presented using the medical model. 

But remember: viewing autism exclusively through this lens is not only limiting—it also fails to give consideration to some of the strengths of being neurodiverse.

Check this blog post to learn a little more about some of the benefits of being autistic.

  1. American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
  2. Centers for Disease Control and Prevention (CDC) (2006). Mental health in the United States: parental report of diagnosed autism in children aged 4-17 years—United States, 2003-2004. Morbidity and Mortality Weekly Report, 55(17), 481–486.
  3. Loomes, R., Hull, L., & Mandy, W. (2017). What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 56(6), 466–474. https://doi.org/10.1016/j.jaac.2017.03.013
  4. Hull, L., Petrides, K. V., & Mandy, W. (2020). The female autism phenotype and Camouflaging: A narrative review. Journal of Autism and Developmental Disorders, 7, 306–317. https://doi.org/10.1007/s40489-020-00197-9
  5. Loomes et al., 2017.
  6. Becerra, T. A., von Ehrenstein, O. S., Heck, J. E., Olsen, J., Arah, O. A., Jeste, S. S., Rodriguez, M., & Ritz, B. (2014). Autism spectrum disorders and race, ethnicity, and nativity: A population-based study. Pediatrics, 134(1), e63–e71. https://doi.org/10.1542/peds.2013-3928
  7. Mandell, D. S., Wiggins, L. D., Carpenter, L. A., Daniels, J., DiGuiseppi, C., Durkin, M. S., Giarelli, E., Morrier, M. J., Nicholas, J. S., Pinto-Martin, J. A., Shattuck, P. T., Thomas, K. C., Yeargin-Allsopp, M., & Kirby, R. S. (2009). Racial/ethnic disparities in the identification of children with autism spectrum disorders. American Journal of Public Health, 99(3), 493–498. https://doi.org/10.2105/AJPH.2007.131243
  8. Alegría, M., NeMoyer, A., Falgàs Bagué, I., Wang, Y., & Alvarez, K. (2018). Social determinants of mental health: Where we are and where we need to go. Current Psychiatry Reports, 20(11), 95. https://doi.org/10.1007/s11920-018-0969-9
  9. APA, 2013, p. 57
  10. Wu, S., Wu, F., Ding, Y., Hou, J., Bi, J., & Zhang, Z. (2017). Advanced parental age and autism risk in children: A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 135(1), 29–41. https://doi.org/10.1111/acps.12666
  11. Ben Itzchak, E., Lahat, E., & Zachor, D. A. (2011). Advanced parental ages and low birth weight in autism spectrum disorders—rates and effect on functioning. Research in Developmental Disabilities, 32(5), 1776–1781. https://doi.org/10.1016/j.ridd.2011.03.004
  12. Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013). Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. The Journal of the American Medical Association, 309(16), 1696–1703. https://doi.org/10.1001/jama.2013.2270
  13. Zhong, C., Tessing, J., Lee, B. K., & Lyall, K. (2020). Maternal dietary factors and the risk of autism spectrum disorders: A systematic review of existing evidence. Autism Research, 13(10), 1634–1658. https://doi.org/10.1002/aur.2402
  14. Cheng, J., Eskenazi, B., Widjaja, F., Cordero, J. F., & Hendren, R. L. (2019). Improving autism perinatal risk factors: A systematic review. Medical Hypotheses, 127, 26–33. https://doi.org/10.1016/j.mehy.2019.03.012
  15. Tick, B., Bolton, P., Happé, F., Rutter, M., & Rijsdijk, F. (2016). Heritability of autism spectrum disorders: A meta-analysis of twin studies. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 57(5), 585–595. https://doi.org/10.1111/jcpp.12499
  16. Colvert, E., Tick, B., McEwen, F., Stewart, C., Curran, S. R., Woodhouse, E., Gillan, N., Hallett, V., Lietz, S., Garnett, T., Ronald, A., Plomin, R., Rijsdijk, F., Happé, F., & Bolton, P. (2015). Heritability of autism spectrum disorder in a UK population-based twin sample. JAMA Psychiatry, 72(5), 415–423. https://doi.org/10.1001/jamapsychiatry.2014.3028
  17. Sandin, S., Lichtenstein, P., Kuja-Halkola, R., Hultman, C., Larsson, H., & Reichenberg, A. (2017). The heritability of autism spectrum disorder. The Journal of the American Medical Association, 318(12), 1182–1184. https://doi.org/10.1001/jama.2017.12141
  18. obins, D. L., Casagrande, K., Barton, M., Chen, C. M., Dumont-Mathieu, T., & Fein, D. (2014). Validation of the modified checklist for autism in toddlers, revised with follow-up (M-CHAT-R/F). Pediatrics, 133(1), 37–45. https://doi.org/10.1542/peds.2013-1813
  19. Hardy, S., Haisley, L., Manning, C., & Fein, D. (2015). Can screening with the Ages and Stages Questionnaire detect autism?. Journal of Developmental and Behavioral Pediatrics, 36(7), 536–543. https://doi.org/10.1097/DBP.0000000000000201
  20. Stone, W. L., McMahon, C. R., & Henderson, L. M. (2008). Use of the screening tool for autism in two-year-olds (STAT) for children under 24 months: An exploratory study. Autism, 12(5), 557–573. https://doi.org/10.1177/1362361308096403
  21. Adamou, M., Jones, S. L., & Wetherhill, S. (2021). Predicting diagnostic outcome in adult autism spectrum disorder using the autism diagnostic observation schedule (2nd ed.). BMC Psychiatry, 21, 24. https://doi.org/10.1186/s12888-020-03028-7
  22. Falkmer, T., Anderson, K., Falkmer, M., & Horlin, C. (2013). Diagnostic procedures in autism spectrum disorders: A systematic literature review. European Child & Adolescent Psychiatry, 22(6), 329–340. https://doi.org/10.1007/s00787-013-0375-0
  23. Sandercock, R. K., Lamarche, E. M., Klinger, M. R., & Klinger, L. G. (2020). Assessing the convergence of self-report and informant measures for adults with autism spectrum disorder. Autism, 24(8), 2256–2268. https://doi.org/10.1177/1362361320942981
  24. McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., & Veenstra-Vanderweele, J. (2011). A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics, 127(5), e1312–e1321. https://doi.org/10.1542/peds.2011-0427
  25. Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., Whitaker, A., & Perrin, J. M. (2012). Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics, 130 Suppl 2, S69–S76.
  26. Esbensen, A. J., Greenberg, J. S., Seltzer, M. M., & Aman, M. G. (2009). A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39(9), 1339–1349. https://doi.org/10.1007/s10803-009-0750-3
  27. Yu, Q., Li, E., Li, L., & Liang, W. (2020). Efficacy of interventions based on Applied Behavior Analysis for autism spectrum disorder: A meta-analysis. Psychiatry Investigation, 17(5), 432–443. https://doi.org/10.30773/pi.2019.0229
  28. Wilkenfeld, D. A., & McCarthy, A. M. (2020). Ethical concerns with Applied Behavior Analysis for autism spectrum “disorder”. Kennedy Institute of Ethics Journal, 30(1), 31–69. https://doi.org/10.1353/ken.2020.0000
  29. Bottema-Beutel, K., & Crowley, S. (2021). Pervasive undisclosed conflicts of interest in Applied Behavior Analysis autism literature. Frontiers in Psychology, 12, 676303. https://doi.org/10.3389/fpsyg.2021.676303
  30. Tiede, G., & Walton, K. M. (2019). Meta-analysis of naturalistic developmental behavioral interventions for young children with autism spectrum disorder. Autism, 23(8), 2080–2095. https://doi.org/10.1177/1362361319836371
  31. Sandbank, M., Bottema-Beutel, K., Crowley, S., Cassidy, M., Dunham, K., Feldman, J. I., Crank, J., Albarran, S. A., Raj, S., Mahbub, P., & Woynaroski, T. G. (2020). Project AIM: Autism intervention meta-analysis for studies of young children. Psychological Bulletin, 146(1), 1–29. https://doi.org/10.1037/bul0000215
  32. Laugeson, A., & Park, M. (2014). Using a CBT approach to teach social skills to adolescents with autism spectrum disorder and other social challenges: The PEERS® method. Journal of Rational-Emotive & Cognitive-Behavior Therapy, 32(1). https://doi.org/10.1007/s10942-014-0181-8
  33. Murphy, S. M., Chowdhury, U., White, S. W., Reynolds, L., Donald, L., Gahan, H., Iqbal, Z., Kulkarni, M., Scrivener, L., Shaker-Naeeni, H., & Press, D. A. (2017). Cognitive behaviour therapy versus a counselling intervention for anxiety in young people with high-functioning autism spectrum disorders: A pilot randomised controlled trial. Journal of Autism and Developmental Disorders, 47(11), 3446–3457. https://doi.org/10.1007/s10803-017-3252-8
  34. Koenig, K., & Levine, M. (2011). Psychotherapy for individuals with autism spectrum disorders. Journal of Contemporary Psychotherapy, 41(1), 29–36. https://doi.org/10.1007/s10879-010-9158-9
  35. Spain, D., Blainey, S. H., & Vaillancourt, K. (2017). Group cognitive behaviour therapy (CBT) for social interaction anxiety in adults with autism spectrum disorders (ASD). Research in Autism Spectrum Disorders, 41-42, 20–30. https://doi.org/10.1016/j.rasd.2017.07.005

© 2022 Ehsan "Essy" Knopf. Any views or opinions represented in this blog are personal and belong solely to the blog owner and do not represent those of people, institutions or organizations that the owner may or may not be associated with in professional or personal capacity, unless explicitly stated. All content found on the EssyKnopf.com website and affiliated social media accounts were created for informational purposes only and should not be treated as a substitute for the advice of qualified medical or mental health professionals. Always follow the advice of your designated provider.